|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 308.93 USD | +1.08% |
|
+1.08% | -12.09% |
| 06-05 | Leerink Partners Adjusts Price Target on Stryker to $407 From $410, Maintains Outperform Rating | MT |
| 06-05 | Worldwide Healthcare Trust outperforms benchmark; praises AstraZeneca | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical Devices & Implants
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 117B | |||||
| 12.86B | |||||
| 7.29B | - | ||||
| 4.12B | |||||
| 2.49B | - | - | - | - | - |
| 2.13B | - | - | - | - | - |
- Stock Market
- Stocks
- SYK Stock
- Charts Stryker Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
